U.S. Health Officials Testify Before Senate Committee About H1N1 Vaccine Campaign

Main Category: Swine Flu
Also Included In: Immune System / Vaccines;  Public Health
Article Date: 19 Nov 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated

U.S. health officials defended their handling of the country's H1N1 (swine flu) vaccine campaign Tuesday "against criticism that their plan to protect Americans was confusing and over-optimistic," Reuters reports (Fox, 11/17).

At a Senate Committee on Homeland Security and Governmental Affairs hearing, HHS and CDC representatives argued "that the roots of the [vaccine] shortage were beyond their control and that they had made the right decisions on matters they could affect" like "not to put immune-boosting adjuvants in the vaccine even though that could have quadrupled the number of doses available now" as well as leaving "decisions about allocating vaccine up to local health departments instead of trying to micromanage them from Atlanta or Washington," the New York Times reports (McNeil, 11/17).

During the hearing, Sens. Joseph Lieberman (I-Conn.) and Susan Collins (R-Maine) questioned why the federal government had not taken action to ensure "the 42 million Americans regarded as most at risk - pregnant women, caregivers of infants, health care workers, children age six months to four years and high-risk children under 18" received the vaccine first when it became clear there were vaccine shortages, CQ HealthBeat reports. Anne Schuchat, of the CDC, "said survey data shows that priority groups are being reached" (Norman, 11/17).

In related news, IRIN examines the most recent statistics on the impact of H1N1 in the Eastern Mediterranean region, as documented by the WHO: Iran leads the region in the number of deaths from H1N1; Syria leads the region in its deaths-to-cases ratio; Kuwait leads in the highest number of cases (11/18).

In a second story, IRIN examines the recent decision by the Afghan government to reopen the all schools to children from November 23 to December 12 to allow children to take exams, following a shut-down to stop the spread of H1N1. Universities, however, will remain closed through the end of the year. The article details preparations underway to prevent the spread of H1N1 upon the students return to the classroom (11/18).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our swine flu section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "U.S. Health Officials Testify Before Senate Committee About H1N1 Vaccine Campaign." Medical News Today. MediLexicon, Intl., 19 Nov. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/171512.php>

APA
Kaiser. (2009, November 19). "U.S. Health Officials Testify Before Senate Committee About H1N1 Vaccine Campaign." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/171512.php.

Please note: If no author information is provided, the source is cited instead.


Swine Flu

Most Popular Articles



Follow Our Swine Flu News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Swine Flu Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »